Xconomy: Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More
Xconomy7 days agoThe long-running patent feud over CRISPR-Cas9 gene editing appears to be over, just as U.S. biotech companies gear up for the first human tests of the landmark technology. This week, a federal ...
Everything You Know About Obesity Is Wrong
MSN News11 hours agoFor decades, the medical community has ignored mountains of evidence to wage a cruel and futile war on fat people, poisoning public perception and ruining millions of lives. It's time for a new approach to this health epidemic.
ALT Up 514% In 2 Days, CRBP Well Stocked, ACAD Soars On FDA Review
RTT News9 hours agoThe following are some of today's top gainers in the pharma/biotech sector..
Corbus Pharmaceuticals stock jumps after biotech purchases hundreds of potential drugs - Boston Business Journal
The Business Journals16 hours agoThe potential drugs are meant to bind to "cannabinoid receptors," which are located on almost every organ and can help regulate immune response, the nervous system and more.
Acorda (ACOR) Stock Dips, FDA Delays Decision on Inbrija
Zacks via Yahoo News7 days agoACOR announced that the FDA has extended time to review its new drug application (NDA), which seeks an approval for its Parkinson's disease candidate Inbrija. The FDA postponed ...
Analysis of sea squirt embryo reveals key molecules in dopaminergic neuron differentiation
EurekAlert!1 day agoIn a new study reported in Genes and Development, a research team centered at University of Tsukuba has developed a novel approach for revealing how the brain forms via the creation of ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and...
Market Watch4 days agoParkinson's disease psychosis. Acadia further stated that ''[t]he FDA approval of NUPLAZID was based on data from the pivotal Phase III Study -020 and other supportive studies, ...
Hemp CBD v. Medical Marijuana
Daytona Beach News-Journal4 days agoHemp cannabidiol oil, commonly referred to as CBD. What tends to trip many consumers up is how hemp CBD oil is different than medical marijuana. The main difference between the two is hemp CBD ...
Larger trial of experimental autism drug planned for 2019 at UCSD, UCLA
The Gazette21 hours agoAn experimental autism drug will be more extensively tested next year by researchers at UC San Diego, where a small clinical trial showed early signs of effectiveness in 2017. The trial ...
ADHD May Increase Risk of Parkinson’s Disease and Similar Disorders
Newswise5 days agoResearchers at University of Utah Health found that ADHD patients had an increased risk of developing Parkinson’s and Parkinson-like diseases than individuals with no ADHD ...
